| FDA | Food and Drug Administration | %FEV1 | % predicted FEV1 |
| EU | European Union | CAT | COPD Assessment Test |
| WHO | World Health Organization | COPD | Chronic obstructive pulmonary disease |
| FCTC | Framework Convention on Tobacco Control | 6MWD | 6 min walking distance |
| HTP | Heated tobacco products | BoE | biomarkers of exposure |
| IQOS | I-Quit-Ordinary-Smoking | BoBEs | biomarkers of biological effect |
| THS | The Tobacco Heating System | DNAm | DNA methylation |
| PD | probing depth | LRRN3 | DNAm biomarker genes |
| CAL | clinical attachment loss | GPR15 | DNAm biomarker genes |
| HnB | heat-not-burn | WID | Whiteness Index for Dentistry |
| MDA | malondialdehyde | FR | fertilization rate |
| 4-HNE | 4-hydroxynonenal | HbA1c | hemoglobin A1c |
| SFR | Salivary flow rate | CT | Computed tomography |
| Lys | lysozyme secretion indicators | OSCC | oral squamous cell carcinoma |
| Lac | lactoferrin secretion indicators | CSE | cigarette-smoke-extract |
| CS | cigarette smokers | p38 | protein |
| ICSI | Intracytoplasmic sperm injection | Ca2+ | calcium ions |
| AMH | anti-Müllerian hormone | 3R4F | reference cigarette smoke |
| SGA | small for gestational age | BEAS-2B | human bronchial epithelial cells |
| IL-8 | interleukin (IL)-8 | DSBs | double-strand breaks |
| IL-6 | Interleukin (IL)-6 | ATR-CHK1 | ataxia telangiectasia, and Rad3-related (ATR) checkpoint kinase 1 (CHK1) |
| IL-2 | interleukin (IL)-2 | MDC1 | Mediators of the DNA damage checkpoint 1 |
| WBC | white blood cells | DNA | deoxyribonucleic acid |
| EVs | extracellular vesicles | NQO1 | target genes |
| HNBC | Heat-Not-Burn cigarette | HMOX1 | target genes |
| TCC | traditional combustion cigarette | VCAM1 | Vascular cell adhesion molecule 1 |
| Nox2-dp | Nox2-derived peptide | CSCs | human atrial cardiac stromal cells |
| ROS | reactive oxygen species | CpG | CpG (cytosine-guanine) dinucleotide in DNA |
| sCD40L | soluble CD40 ligand | RC | reference cigarette |
| H2O2 | hydrogen peroxide | mRNA | messenger RNA |
| NO | nitric oxide | CYP1A1 | cytochrome P450 family 1 subfamily Member 1 |
| FMD | flow-mediated dilation | hPDL | human periodontal ligament cells |
| PLT | platelets | eCV | electronic cigarette vapor |
| HDL-C | high-density lipoprotein cholesterol | S and G2/M | S and G2/M cell cycle phases |
| NTV | novel tobacco vapor | p53, Bcl2, p21 | genes |
| BoPH | biomarkers of potential harm | MRC5 | human lung fibroblast cells |
| CC | conventional cigarette | HMC3 | human microglial cells |
| NNAL | 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol | HSC-3 | human oral squamous cell carcinoma cell line |
| 2,3-d-TXB2 | 2,3-dinor thromboxane B2 | A549 | human lung adenocarcinoma cells |
| NS | never-smokers | P450 | cytochrome P450 |
| CO | carbon monoxide | γH2AX | phosphorylated H2AX |
| CFR | coronary flow reserve | HOK | human oral keratinocytes |
| TAC | total arterial compliance | H2AX | histone H2A variant |
| GLS | global longitudinal strain | IL1ꞵ | Interleukin (IL)-1ꞵ |
| GWW | wasted myocardial work | IL4 | Interleukin (IL)-4 |
| TxB2 | thromboxane B2 | IL-13 | Interleukin (IL)-13 |
| AEP | acute eosinophilic pneumonia | PBMC | peripheral blood mononuclear cells |
| FEV 1 | forced expiratory volume in 1 s | J-ECOH | the Japan Epidemiology Collaboration on Occupational Health |
| hs-CRP | high-sensitivity C-reactive protein | IL-16 | Interleukin (IL)-16 |
| NOS | the Newcastle-Ottawa Scale | HGF | cytokines |
| RCTs | Randomized controlled trials | Gro-α, MCP-1, SCF, MIG, IP-10 | chemokines |
| NNK | biomarkers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone | G-CSF | granulocyte colony-stimulating factor |
| PR | the prevalence ratio | TRAIL | protein TNF-related apoptosis-inducing ligand, cytokine |
| IFNγ | interferon gamma | SFR | the salivary flow rate |
| GO | Gene ontology | OR | odds ratio |
| sICAM-1 | soluble intercellular adhesion molecule-1 | χ2 | Chi-square test |
| HR | hazard ratio | NNN | N-nitrosonornicotine |
| sNox2-p | Serum levels of Nox2-derived peptide |